N-(Prop-2-yn-1-yl)-2,3-dihydro-1H-inden-1-amine
CAS:1875-50-9
Formula:
C12H13N
Purity:
95%
Color and Shape:
Liquid
Molecular weight:
171.2383
Ref: IN-DA003SA1
1g | 143.00 € | ||
5g | 496.00 € | ||
100mg | 57.00 € | ||
250mg | 77.00 € |
Estimated delivery in United States, on Tuesday 26 Nov 2024
rac-Rasagiline
Formula:
C12H13N
Color and Shape:
White To Colorless Semi-Solid To Liquid
Molecular weight:
171.24
Ref: 4Z-R-192
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Wednesday 27 Nov 2024
Ref: 54-OR965634
1g | 136.00 € |
Estimated delivery in United States, on Tuesday 3 Dec 2024
N-(Prop-2-yn-1-yl)-2,3-dihydro-1H-inden-1-amine
CAS:1875-50-9
Purity:
95.0%
Color and Shape:
Liquid
Molecular weight:
171.2429962158203
Ref: 10-F447170
1g | 109.00 € | ||
5g | To inquire |
Estimated delivery in United States, on Tuesday 10 Dec 2024
N-(2-Propynyl)-2,3-dihydroinden-1-amine
Controlled ProductCAS:1875-50-9
Applications N-(2-PROPYNYL)-2,3-DIHYDROINDEN-1-AMINE (cas# 1875-50-9) is a useful research chemical.
Formula:
C12H13N
Color and Shape:
Dark Yellow
Molecular weight:
171.238
Ref: TR-P839215
50mg | 274.00 € | ||
250mg | 1,163.00 € | ||
500mg | 1,814.00 € |
Estimated delivery in United States, on Tuesday 10 Dec 2024
N-(2-Propynyl)-2,3-dihydroinden-1-amine
CAS:1875-50-9
N-(2-Propynyl)-2,3-dihydroinden-1-amine is an inhibitor of monoamine oxidase B (MAO-B) and has neuroprotective properties. It has …
Formula:
C12H13N
Purity:
Min. 95%
Molecular weight:
171.24 g/mol
Ref: 3D-BAA87550
1g | 310.00 € | ||
2g | 465.00 € | ||
5g | 801.00 € | ||
10g | 1,276.00 € | ||
500mg | 194.00 € |
Estimated delivery in United States, on Tuesday 7 Jan 2025
Racemic rasagiline
CAS:1875-50-9
Racemic rasagiline (AGN-1135), an MAOI, can cause a hypertensive crisis with tyramine foods. TVP-1022, its …
Formula:
C12H13N
Color and Shape:
Solid
Molecular weight:
171.24
Ref: TM-T71910
25mg | 1,386.00 € | ||
50mg | 1,805.00 € | ||
100mg | 2,279.00 € |
Estimated delivery in United States, on Tuesday 14 Jan 2025